These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 31030099)
1. Aspernolide F, as a new cardioprotective butyrolactone against doxorubicin-induced cardiotoxicity. El-Agamy DS; Ibrahim SRM; Ahmed N; Khoshhal S; Abo-Haded HM; Elkablawy MA; Aljuhani N; Mohamed GA Int Immunopharmacol; 2019 Jul; 72():429-436. PubMed ID: 31030099 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis. Zhang J; Cui L; Han X; Zhang Y; Zhang X; Chu X; Zhang F; Zhang Y; Chu L Biomed Pharmacother; 2017 Sep; 93():1253-1260. PubMed ID: 28738542 [TBL] [Abstract][Full Text] [Related]
3. Crocin protects against cardiotoxicity induced by doxorubicin through TLR-2/NF-κB signal pathway in vivo and vitro. Chu X; Zhang Y; Xue Y; Li Z; Shi J; Wang H; Chu L Int Immunopharmacol; 2020 Jul; 84():106548. PubMed ID: 32388215 [TBL] [Abstract][Full Text] [Related]
4. Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats. Ibrahim Fouad G; Ahmed KA Cardiovasc Toxicol; 2022 Feb; 22(2):152-166. PubMed ID: 34837640 [TBL] [Abstract][Full Text] [Related]
6. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133 [TBL] [Abstract][Full Text] [Related]
7. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis. Shaker RA; Abboud SH; Assad HC; Hadi N BMC Pharmacol Toxicol; 2018 Jan; 19(1):3. PubMed ID: 29321061 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats. Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614 [TBL] [Abstract][Full Text] [Related]
9. Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways. El-Ela SRA; Zaghloul RA; Eissa LA Nutrition; 2022 Oct; 102():111732. PubMed ID: 35816809 [TBL] [Abstract][Full Text] [Related]
10. Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway. Abbas NAT; Kabil SL Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1145-1153. PubMed ID: 28780599 [TBL] [Abstract][Full Text] [Related]
11. Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats. Haybar H; Goudarzi M; Mehrzadi S; Aminzadeh A; Khodayar MJ; Kalantar M; Fatemi I Biomed Pharmacother; 2019 Jan; 109():530-535. PubMed ID: 30551518 [TBL] [Abstract][Full Text] [Related]
12. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995 [TBL] [Abstract][Full Text] [Related]
13. The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials. Alharbi FK; Alshehri ZS; Alshehri FF; Alhajlah S; Khalifa HA; Dahran N; Ghonimi WAM Open Vet J; 2023 Dec; 13(12):1718-1728. PubMed ID: 38292716 [TBL] [Abstract][Full Text] [Related]
14. Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-α. Ma T; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL Mol Biol Rep; 2019 Feb; 46(1):105-118. PubMed ID: 30362071 [TBL] [Abstract][Full Text] [Related]
15. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity. Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227 [TBL] [Abstract][Full Text] [Related]
17. Assessing the cardioprotective effect of necrosulfonamide in doxorubicin-induced cardiotoxicity in mice. Abbas SF; Abdulkadim H; Hadi NR J Med Life; 2023 Oct; 16(10):1468-1473. PubMed ID: 38313169 [TBL] [Abstract][Full Text] [Related]
18. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways. El-Said NT; Mohamed EA; Taha RA Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):647-658. PubMed ID: 30734091 [TBL] [Abstract][Full Text] [Related]
19. Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation. Sangomla S; Saifi MA; Khurana A; Godugu C J Trace Elem Med Biol; 2018 May; 47():53-62. PubMed ID: 29544808 [TBL] [Abstract][Full Text] [Related]
20. The Cardenolide Glycoside Acovenoside A Affords Protective Activity in Doxorubicin-Induced Cardiotoxicity in Mice. Ezzat SM; El Gaafary M; El Sayed AM; Sabry OM; Ali ZY; Hafner S; Schmiech M; Jin L; Syrovets T; Simmet T J Pharmacol Exp Ther; 2016 Aug; 358(2):262-70. PubMed ID: 27247000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]